Events in February 2020
MonMonday | TueTuesday | WedWednesday | ThuThursday | FriFriday |
---|---|---|---|---|
January 27, 2020
|
January 28, 2020
|
January 29, 2020
|
January 30, 2020
|
January 31, 2020
|
February 3, 2020
|
February 4, 2020(2 events)
10:30 am: Country Analytics & OptimizationCountry Analytics & Optimization 10:30 am - 11:30 am
Country level analytics are essential for understanding how the timeline for your trial will unfold. Essential metrics for country selection and planning will be presented along with a framework for how true country level analytics are constructed from country specific source data. 5:30 pm: Country Analytics & OptimizationCountry Analytics & Optimization 5:30 pm - 6:30 pm
Country level analytics are essential for understanding how the timeline for your trial will unfold. Essential metrics for country selection and planning will be presented along with a framework for how true country level analytics are constructed from country specific source data. |
February 5, 2020(2 events)
10:30 am: R&D Advantage Report: Key Productivity Metrics for R&DR&D Advantage Report: Key Productivity Metrics for R&D 10:30 am - 11:30 am
Building on its long history of measuring R&D performance, KMR creates this new flagship report built from its own proprietary research and methods to provide senior management at companies of all sizes with access to key performance indicators in BioPharma R&D. The report is designed for companies of all sizes but especially for small to mid-cap biopharma that have limited data of their own but who are looking for a trusted and reliable resource for benchmarking data that can be used for goal setting and understanding how different approaches to R&D are impacting productivity. This is a high level assessment examining cycle time, success rates, productivity, and value. Sponsors Only 5:30 pm: R&D Advantage Report: Key Productivity Metrics for R&DR&D Advantage Report: Key Productivity Metrics for R&D 5:30 pm - 6:30 pm
Building on its long history of measuring R&D performance, KMR creates this new flagship report built from its own proprietary research and methods to provide senior management at companies of all sizes with access to key performance indicators in BioPharma R&D. The report is designed for companies of all sizes but especially for small to mid-cap biopharma that have limited data of their own but who are looking for a trusted and reliable resource for benchmarking data that can be used for goal setting and understanding how different approaches to R&D are impacting productivity. This is a high level assessment examining cycle time, success rates, productivity, and value. Sponsors Only |
February 6, 2020(2 events)
10:30 am: Country Analytics & OptimizationCountry Analytics & Optimization 10:30 am - 11:30 am
Country level analytics are essential for understanding how the timeline for your trial will unfold. Essential metrics for country selection and planning will be presented along with a framework for how true country level analytics are constructed from country specific source data. 5:30 pm: Country Analytics & OptimizationCountry Analytics & Optimization 5:30 pm - 6:30 pm
Country level analytics are essential for understanding how the timeline for your trial will unfold. Essential metrics for country selection and planning will be presented along with a framework for how true country level analytics are constructed from country specific source data. |
February 7, 2020
|
February 10, 2020
|
February 11, 2020(2 events)
10:30 am: Trial Cost Analytics - Benchmarks, Productivity & Predictive ModelsTrial Cost Analytics - Benchmarks, Productivity & Predictive Models 10:30 am - 11:30 am
Framework on how Trial Cost data is being used to measure operational efficiency, identify key cost drivers, benchmark performance, and set cost forecasts using predictive cost models. As the pharmaceutical industry looks for improvements in performance, KMR’s Trial Cost Program offers companies competitive advantage by offering a view into how simple design choices can not only streamline costs but also have the added benefit of reducing cycle times and accelerating time to market. Sponsors Only 5:30 pm: Trial Cost Analytics - Benchmarks, Productivity & Predictive ModelsTrial Cost Analytics - Benchmarks, Productivity & Predictive Models 5:30 pm - 6:30 pm
Framework on how Trial Cost data is being used to measure operational efficiency, identify key cost drivers, benchmark performance, and set cost forecasts using predictive cost models. As the pharmaceutical industry looks for improvements in performance, KMR’s Trial Cost Program offers companies competitive advantage by offering a view into how simple design choices can not only streamline costs but also have the added benefit of reducing cycle times and accelerating time to market. Sponsors Only |
February 12, 2020(2 events)
10:30 am: R&D Advantage Report: Key Productivity Metrics for R&DR&D Advantage Report: Key Productivity Metrics for R&D 10:30 am - 11:30 am
Building on its long history of measuring R&D performance, KMR creates this new flagship report built from its own proprietary research and methods to provide senior management at companies of all sizes with access to key performance indicators in BioPharma R&D. The report is designed for companies of all sizes but especially for small to mid-cap biopharma that have limited data of their own but who are looking for a trusted and reliable resource for benchmarking data that can be used for goal setting and understanding how different approaches to R&D are impacting productivity. This is a high level assessment examining cycle time, success rates, productivity, and value. Sponsors Only 5:30 pm: R&D Advantage Report: Key Productivity Metrics for R&DR&D Advantage Report: Key Productivity Metrics for R&D 5:30 pm - 6:30 pm
Building on its long history of measuring R&D performance, KMR creates this new flagship report built from its own proprietary research and methods to provide senior management at companies of all sizes with access to key performance indicators in BioPharma R&D. The report is designed for companies of all sizes but especially for small to mid-cap biopharma that have limited data of their own but who are looking for a trusted and reliable resource for benchmarking data that can be used for goal setting and understanding how different approaches to R&D are impacting productivity. This is a high level assessment examining cycle time, success rates, productivity, and value. Sponsors Only |
February 13, 2020(2 events)
10:30 am: Trial Cost Analytics - Benchmarks, Productivity & Predictive ModelsTrial Cost Analytics - Benchmarks, Productivity & Predictive Models 10:30 am - 11:30 am
Framework on how Trial Cost data is being used to measure operational efficiency, identify key cost drivers, benchmark performance, and set cost forecasts using predictive cost models. As the pharmaceutical industry looks for improvements in performance, KMR’s Trial Cost Program offers companies competitive advantage by offering a view into how simple design choices can not only streamline costs but also have the added benefit of reducing cycle times and accelerating time to market. Sponsors Only 5:30 pm: Trial Cost Analytics - Benchmarks, Productivity & Predictive ModelsTrial Cost Analytics - Benchmarks, Productivity & Predictive Models 5:30 pm - 6:30 pm
Framework on how Trial Cost data is being used to measure operational efficiency, identify key cost drivers, benchmark performance, and set cost forecasts using predictive cost models. As the pharmaceutical industry looks for improvements in performance, KMR’s Trial Cost Program offers companies competitive advantage by offering a view into how simple design choices can not only streamline costs but also have the added benefit of reducing cycle times and accelerating time to market. Sponsors Only |
February 14, 2020
|
February 17, 2020
|
February 18, 2020
|
February 19, 2020(1 event)
10:30 am: LIVE Clinical Cycle Time Program: Establishing A Framework For Company PerformanceLIVE Clinical Cycle Time Program: Establishing A Framework For Company Performance 10:30 am - 11:30 am
Measuring the performance of clinical trial trials requires a solid framework of how and what to measure grounded by standard definitions and an unbiased third party to ensure data integrity. The data is just the beginning, KMR Group creates benchmarks and advanced analytics that drive insight from specific pain points to statistically validated drivers of duration. Companies participating in the program benefit from access to reports, tools, members only webinars, user meetings and options for a la carte or project specific consulting opportunities that are all grounded by our peerless data sources. Find out more about why the most innovative companies in the industry rely on KMR to help them drive performance improvements by over 30% using the most reliable and trusted dataset in the industry. |
February 20, 2020
|
February 21, 2020
|
February 24, 2020
|
February 25, 2020(2 events)
10:30 am: Clinical Cycle Time Program: Establishing A Framework For Company PerformanceClinical Cycle Time Program: Establishing A Framework For Company Performance 10:30 am - 11:30 am
Measuring the performance of clinical trial trials requires a solid framework of how and what to measure grounded by standard definitions and an unbiased third party to ensure data integrity. The data is just the beginning, KMR Group creates benchmarks and advanced analytics that drive insight from specific pain points to statistically validated drivers of duration. Companies participating in the program benefit from access to reports, tools, members only webinars, user meetings and options for a la carte or project specific consulting opportunities that are all grounded by our peerless data sources. Find out more about why the most innovative companies in the industry rely on KMR to help them drive performance improvements by over 30% using the most reliable and trusted dataset in the industry. 5:30 pm: Clinical Cycle Time Program: Establishing A Framework For Company PerformanceClinical Cycle Time Program: Establishing A Framework For Company Performance 5:30 pm - 6:30 pm
Measuring the performance of clinical trial trials requires a solid framework of how and what to measure grounded by standard definitions and an unbiased third party to ensure data integrity. The data is just the beginning, KMR Group creates benchmarks and advanced analytics that drive insight from specific pain points to statistically validated drivers of duration. Companies participating in the program benefit from access to reports, tools, members only webinars, user meetings and options for a la carte or project specific consulting opportunities that are all grounded by our peerless data sources. Find out more about why the most innovative companies in the industry rely on KMR to help them drive performance improvements by over 30% using the most reliable and trusted dataset in the industry. |
February 26, 2020
|
February 27, 2020
|
February 28, 2020
|